Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesCentral Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Schlote T et al. – Topical therapy with the prostaglandin derivate travoprost is accompanied by a significant reduction of CCT within one year of treatment. Further clinical studies are needed to evaluate the possible long–term effects of prostaglandins on the CCT of glaucoma patients.
Related Articles
Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09
Relevance Score: 93%
Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09
Relevance Score: 92%
Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09
Relevance Score: 91%
Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09
Relevance Score: 91%
Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09
Relevance Score: 91%
Today in Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ex Vivo Protein Deposition on Bi-Weekly Silicone Hydrogel Contact Lenses
Optometry and Vision Science, 12/03/09
Tear Physiology of Aqueous Deficiency and Evaporative Dry Eye
Optometry and Vision Science, 12/03/09
Adding a microcomputer bar-code network to a minicomputer-based radiology information system
Journal of Digital Imaging, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor